Improving care for infants with complex heart conditions

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This initiative aims to enhance the care and outcomes for infants diagnosed with Hypoplastic Left Heart Syndrome (HLHS) by expanding a national registry to collect clinical and developmental data. It focuses on implementing consensus standards into daily practices across pediatric cardiology centers and actively involves parents in the care process. The study will gather information on infants from diagnosis until they reach 12 months of age, facilitating better understanding and management of HLHS.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Fetuses or newborns diagnosed with HLHS or other univentricular condition
* Intended to undergo Norwood procedure

Exclusion Criteria:

* None

Where it's running

• Phoenix Children's Hospital
  Phoenix, Arizona, United States Recruiting
• Arkansas Children's Hospital
  Little Rock, Arkansas, United States Recruiting
• Children's Hospital Los Angeles
  Los Angeles, California, United States Recruiting
• UCLA Mattel Children's Hospital
  Los Angeles, California, United States Recruiting
• Lucile Packard Children's Hospital-Stanford
  Palo Alto, California, United States Recruiting
• Sutter Medical Center-Sacramento
  Sacramento, California, United States Recruiting

+13 more sites. See ClinicalTrials.gov for the full list.

Study contacts

• Principal investigator: Garick Hill, MD — Cininnati Children's Hospital Medical Center
• Study coordinator: Mark Timbers
• Email: mark.timbers@cchmc.org

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Long-term safety follow-up after autologous cardiac stem cells in kids with single ventricle heart disease

  This study checks whether autologous cardiac stem cells (JRM-001) remain safe for up to a year in children who already received them after heart reconstructive surgery.

  Recruiting Metcela Inc. · Okayama, Okayama-ken · NCT07884318

• Integrated prenatal and postnatal treatment for newborns with critical congenital heart disease

  This study is testing a new approach that combines care before and after birth for newborns with serious heart defects to see if it can improve their treatment and recovery.

  Recruiting Beijing Anzhen Hospital · Beijing · NCT06768008

• Allogeneic HCT for Refractory sJIA in Children and Young Adults

  This study tests whether donor blood-forming cell transplantation can help children and young adults with difficult-to-treat systemic JIA, including those with lung involvement.

  Recruiting Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio · NCT07845942

• Proton MRI of Musculoskeletal and Lung Health

  This study tests MRI techniques to take clearer pictures of the lungs in healthy people and those with lung, muscle, or bone conditions.

  Recruiting Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio · NCT07845708

• See how well the lungs distribute dissolved xenon gas during MRI in HSCT patients and others

  This study tests a special MRI method using hyperpolarized xenon gas to visualize how gas and dissolved xenon move through the lungs in people who have HSCT, respiratory issues, or are healthy controls.

  Recruiting Phase 1/2 Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio · NCT07823036

• Semaglutide for teens with autism and obesity

  This 6-month, two-arm study tests whether semaglutide can help reduce BMI in adolescents 12-18 with autism and obesity, alongside lifestyle counseling.

  Recruiting Phase 4 Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio · NCT07770152

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.